Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anesthesia analgesia drug composition and preparation method thereof

A composition and drug technology, applied in the field of medicine, can solve the problems of easy occurrence of morning insomnia, daytime anxiety, low blood pressure and extrapyramidal symptoms, and achieve the effects of protecting physical and mental health, reducing the amount of auxiliary materials and improving stability.

Active Publication Date: 2018-06-12
YICHANG HUMANWELL PHARMA
View PDF6 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] Clinically, the compound represented by the formula (I) is used as a short-acting sedative for procedural sedation, induction and maintenance of general anesthesia, sedation for ICU patients, etc., but patients are prone to symptoms such as early morning insomnia and daytime anxiety after medication; Mazolam (compound represented by formula (I) (R is methyl)) can cause adverse reactions such as uptake inhibition and drug accumulation, with obvious hypotension and extrapyramidal symptoms

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anesthesia analgesia drug composition and preparation method thereof
  • Anesthesia analgesia drug composition and preparation method thereof
  • Anesthesia analgesia drug composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Embodiment 1: Preparation of the composition of narcotic analgesic drug

[0045] prescription:

[0046]

[0047] Preparation method: according to the feeding ratio, put dextran and glycine into about 90% of the prescription amount of water for injection to dissolve, and use a pH regulator to adjust the pH value of the above solution to 2.5-3.7. Then add formula (I) besylate and remifentanil hydrochloride while stirring, stir until completely dissolved, measure the pH of the solution to be 2.5 to 3.7, and then dilute to the full prescription amount with water for injection. Add 0.1% (w / v) medicinal charcoal according to the volume of the solution, and stir for 30 minutes. The medicinal solution is first filtered with a 0.45 μm microporous membrane, and then filtered with a 0.22 μm microporous membrane.

[0048] Freeze-drying process:

[0049] (1) Pre-freezing stage: After filling the filtered liquid, put it into the freeze-drying cabinet, start the freeze-drying ma...

Embodiment 2

[0053] Embodiment 2: Preparation of the composition of narcotic analgesic drug

[0054] prescription:

[0055]

[0056]

[0057] Preparation method: according to the feeding ratio, put lactose into about 90% of the prescription amount of water for injection to dissolve, and adjust the pH value of the above solution to 3.5-4.8 with a pH regulator. Then add formula (I) besylate and fentanyl citrate while stirring, stir until completely dissolved, measure the pH value of the solution to be 3.5 to 4.8, then dilute to the full amount of the prescription with water for injection. Add 0.01% (w / v) medicinal charcoal according to the volume of the solution, and stir for 40 minutes. The medicinal solution is first filtered with a 0.45 μm microporous membrane, and then filtered with a 0.22 μm microporous membrane.

[0058] Freeze-drying process:

[0059] (1) Pre-freezing stage: After filling the filtered liquid, put it into the freeze-drying cabinet, start the freeze-drying mach...

Embodiment 3

[0063] Embodiment 3: Preparation of the composition of narcotic analgesic drug

[0064] prescription:

[0065] components

Dosage

Compound benzenesulfonate shown in formula (I) (R is methyl, in base)

35g

Sufentanil citrate (calculated by base)

1.2g

Dextran

7g

Mannitol

85g

pH regulator

Appropriate amount

Water for Injection

Dilute to 1000ml

[0066] Preparation method: according to the feeding ratio, put dextran and mannitol into about 90% of the prescription amount of water for injection to dissolve, and use a pH regulator to adjust the pH value of the above solution to 3.8-4.5. Then add formula (I) besylate and sufentanil citrate while stirring, stir until completely dissolved, measure the pH value of the solution to be 3.8 to 4.5, and then dilute to the full amount of the prescription with water for injection. Add 0.05% (w / v) medicinal charcoal according to the volume of the solution, and stir fo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an anesthesia analgesia drug composition. The drug composition comprises a compound drug composition which can serve as a sedative hypnotic drug and contains rRemimazolam, derivatives of rRemimazolam and a narcotics analgesic.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a compound pharmaceutical composition comprising remimazolam and its derivatives (compounds represented by formula I) and narcotic analgesics which can be used as sedative-hypnotics, in particular to a compound pharmaceutical composition comprising remimazolam Freeze-dried powder preparation of its derivatives and narcotic analgesic agent. Background technique [0002] Compound benzodiazepine shown in formula (I) as follows: [0003] [0004] R is H, CH 3 , ethyl, isopropyl. [0005] The compound of formula (I) is a novel benzodiazepine compound, which belongs to a short-acting sedative. Clinically, it can be used for procedural sedation, induction and maintenance of general anesthesia, sedation of ICU patients, etc. Short-acting sedatives allow the patient to regain consciousness quickly and be discharged from the hospital as soon as possible. In the face of the gradual...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/445A61K31/4468A61K31/4535A61K31/485A61K31/5517A61K47/18A61K47/26A61K47/36A61K9/19A61P25/22A61P25/20A61P25/08A61P25/04A61P21/02A61P23/00
CPCA61K9/19A61K31/445A61K31/4468A61K31/4535A61K31/485A61K31/5517A61K47/183A61K47/26A61K47/36A61K2300/00
Inventor 李仕群李莉娥李杰杜文涛符义刚田峦鸢吕金良曲龙妹黄明来郭建锋吴有斌张敏
Owner YICHANG HUMANWELL PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com